Congenital AfibrinogenemiaSymptoms, Doctors, Treatments, Advances & More
Congenital Afibrinogenemia Overview
Learn About Congenital Afibrinogenemia
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Alessandro Casini practices practicing medicine in Geneve, Switzerland. Mr. Casini is rated as an Elite expert by MediFind in the treatment of Congenital Afibrinogenemia. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Dysfibrinogenemia, Familial Hypofibrinogenemia, Congenital Afibrinogenemia, Blood Clots, and Bone Marrow Transplant.
Flora Peyvandi practices practicing medicine in Milan, Italy. Ms. Peyvandi is rated as an Elite expert by MediFind in the treatment of Congenital Afibrinogenemia. She is also highly rated in 37 other conditions, according to our data. Her clinical expertise encompasses Blood Clots, Hemophilia A, Von Willebrand Disease (VWD), Synovectomy, and Bone Marrow Transplant.
Claudia Khayat practices practicing medicine in Hotel Dieu, Lebanon. Ms. Khayat is rated as an Elite expert by MediFind in the treatment of Congenital Afibrinogenemia. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Congenital Afibrinogenemia, Familial Hypofibrinogenemia, Blood Clots, and Hemophilia A.
Summary: This study is a phase 3, prospective, single center, randomized, open label, controlled, parallel arm, interventional study to investigate the efficacy and safety of CSL511, in participants undergoing cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) for pseudomyxoma peritonei (PMP) with predicted intraoperative blood loss of greater than or equal to (\>=) 2 liter ...
Summary: The objective of this prospective, randomized controlled study was to evaluate the effectiveness of this NCH gel in the prevention of IUA development as assessed by hysteroscopy after USG-MVA, in the treatment for first-trimester miscarriage. * To study the severity and extent of the IUA as assessed by the AFS and ESGE adhesion score in both groups of patients. * To examine the rate of complicatio...